What a buyer sees
GENEA BIOMEDX UK LIMITED
Other research and experimental development on natural sciences and engineering · Sandwich · 08314520
8staff · FY2022
14years trading
46oldest owner on file
£503kcash at bank
Your turnover is on public record
filed£6.4Mfor the year to 2022
Unusual at this size, and it works in your favour: a buyer is reading your number rather than guessing at one.
What your filings show moving
Staff8
202112 → 82022
Cash at bank£503k
2021£316k → £503k2022
How you sit in your trade
slowest tenth typical fastest tenth youSales per employee£801,675above almost all
£16,018£98,546£291,958
Debtor daysdays31in the bottom quarter
2677152
Creditor daysdays1
1231270
Stock daysdays96in the top quarter
632182
Each spread is companies in the same trade and size that did publish a turnover. Creditor days are shown but not marked: neither end of that one is plainly good.
What a buyer would ask 4
- The newest accounts on file are 44 months oldAnyone looking at the company today is reading a year that has already ended. Whatever has improved since is invisible.
- Headcount fell from 11 to 8A buyer sees the fall and not the reason. Deliberate tightening and losing people look identical on a filing.
- Stock days run high for your tradeYours is 96 against 32 for the middle of 232 comparable companies. That gap is working capital a buyer has to fund on day one, and it comes off the price.
- No website on file against the companyThe first thing anyone does with a company number is look for the business behind it. Finding nothing is its own answer.
What a buyer would like 2
- Sales per employee better than three quarters of your tradeYours is 801,675 against 98,546 for the middle of 48 comparable companies.
- Debtor days better than three quarters of your tradeYours is 31 against 77 for the middle of 42 comparable companies.
What the register says
Owners
- 46since 2023
Directors
No current directors loaded.
| Year to | Turnover | Staff | Cash |
|---|---|---|---|
| 2022-12-31 | £6.4M | 8 | £503k |
| 2021-12-31 | £3.0M | 11 | £826k |
| 2021-06-30 | £5.1M | 12 | £316k |
A rough bracket, and why it is only that
0.4–0.9× sales£2.6M£5.8M
The turnover range is fitted on UK companies that did file one. The multiple is a published sector average from Dutch mid-market deals, not from your own numbers and not from your own market. Treat this as the opening bracket of a conversation, not a valuation.